Alex Goldberg

Banco Bradesco S.A. (NYSE:BBD) and Abbott Laboratories (NYSE:ABT) Added to Equity Profile Report's NYSE Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/20/2013 -- -- Equity Profile Report expands its NYSE Decliners Weekly Watch List adding Banco Bradesco S.A. (NYSE:BBD) and Abbott Laboratories (NYSE:ABT).

Banco Bradesco S.A. (NYSE:BBD) a company that provides a range of banking and financial products and services to individuals; large, mid-sized, and small companies; and local and international corporations and institutions in Brazil and internationally closed down in its previous session (-0.87%) on 10,697,042 shares traded. Banco Bradesco S.A. (NYSE:BBD) is currently down (-31.03%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Banco Bradesco S.A. (NYSE:BBD)

Abbott Laboratories (NYSE:ABT) a company that engages in the discovery, development, manufacture, and sale of health care products worldwide closed down in its previous session (-0.24%) on 7,756,376 shares traded after Abbott Announced to Present at J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2014. Abbott Laboratories (NYSE:ABT) is currently down (-2.65%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Abbott Laboratories (NYSE:ABT)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com